REGENXBIO Inc. — Form D
REGENXBIO Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-23. The offering totals $30.0M, of which $27.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-01-23
- Form: D
- Accession: 0001590877-15-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $27.5M
- Remaining: $2.5M
- Investors: 15
- Date of first sale: 2015-01-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-232797
Issuer
- Name: REGENXBIO Inc.
- CIK: 0001590877
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9712 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Phone: 240-552-8181
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| John Daniel Kiser | Director | Washington, DC |
| Donald J Hayden, Jr. | Director | Philadelphia, PA |
| Allan M Fox | Director | Washington, DC |
| Luke J Beshar | Director | Rockville, MD |
| Camille J Samuels | Director | Rockville, MD |
| Kenneth T Mills | Director | Rockville, MD |
| Kenneth T Mills | Executive Officer | Rockville, MD |
| Benjamin T Auspitz | Director | Rockville, MD |
| Daniel T Kiser | Director | Washington, DC |
| Allan T Fox | Director | Washington, DC |
| Don T Hayden | Director | Washington, DC |
Other filings by this issuer (2)
More